Atrium Therapeutics, Inc. (RNA)
Atrium Therapeutics, Inc. (RNA) tracked by StreetAlpha. It last closed at $8.55 on Nov 2. RNA reports earnings on Thu, Nov 12, 2026. The average 12-month price target from 2 analysts is $17.50 (+104.7% from the last close), with a high of $20.00 and a low of $15.00.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 2 analysts who set a price target on RNA in the past 90 days. The average target is $17.50, with a high of $20.00 and a low of $15.00, compared with the last close of $8.55.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 28 | HC Wainwright & Co. | Target lowered | Buy | $25 → $20 |
| Oct 22 | Roth Capital | Initiated | Buy | $15 |
| Aug 14 | HC Wainwright & Co. | Reiterated | Buy | $25 |
| Aug 6 | HC Wainwright & Co. | Initiated | Buy | $25 |
| Jun 18 | Cantor Fitzgerald | Initiated | Buy | $25 |
Technical Analysis
The stock sits between its 20 and 50 day averages. Momentum is improving (RSI 51). The nearest support is the Pivot at $8.46, and the nearest resistance the Pivot R1 at $8.73.
| RSI (14) | 50.80 | Middle of its range | Neutral |
| MACD | -0.25 | Above its signal line | Bullish |
| Stochastic | 75.0 | Middle of its range | Neutral |
| ADX (14) | 31.1 | Trending down | |
| Williams %R | -8.6 | Oversold below −80, overbought above −20 | Overbought |
| CCI (20) | 139.0 | Oversold below −100, overbought above 100 | Overbought |
| Rate of change | +12.3% | Change over 10 sessions | Bullish |
| ATR (14) | $0.42 | Typical daily range, 4.9% of price |
| RSI (14) | 35.72 | Weak, oversold below 30 | Neutral |
| MACD | -1.40 | Below its signal line | Bearish |
| Stochastic | 11.8 | Near the bottom of its range | Oversold |
| ADX (14) | 26.1 | Trending down | |
| Williams %R | -85.3 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -80.2 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −37.3% | Change over 10 sessions | Bearish |
| ATR (14) | $1.22 | Typical daily range, 14.2% of price |
What happened before
See how RNA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90DNo whale options trades in RNA in the last 90 days.
RNA Institutional Ownership
Hedge fund holdings →- Crcm LP+1.3M sh$17.3M
- Sessa Capital IM, L.P.+949K sh$12.8M
- Arbiter Partners Capital Management LLC+293K sh$3.9M
- Cantor Fitzgerald, L. P.+278K sh$3.7M
- BlackRock, Inc.+242K sh$3.3M
- AQR Capital Management LLC+172K sh$2.3M
- RA Capital Management, L.P.−864K sh−$11.6M
- Pentwater Capital Management LP−603K sh−$8.1M
- O'Connor Alternative Investments LLC−578K sh−$7.7M
- Farallon Capital Management, L.l.c.−349K sh−$4.7M
- Bellevue Group AG−263K sh−$3.5M
- Vanguard Portfolio Management LLC−243K sh−$3.3M
- Y-Intercept (Hong Kong) LtdSold out−35K shOct 16
- Trium Capital LLPTrimmed−55K shOct 16
- Moran Wealth Management, LLCSold out−33K shOct 22
- Fractal Investments LLCSold out−20K shOct 28
- Wealth Enhancement Advisory Services, LLCNew+12K shOct 13
- Kestra Private Wealth Services, LLCAdded+1,710 shOct 30
- Strs OhioAdded+1,100 shOct 30
- Versant Capital Management, IncAdded+666 shOct 2
From SEC Form 13F filings by funds managing over $100 million, as of Jun 30, 2026. Changes compare each fund with its own Q1 2026 filing. Filings come up to 45 days after the quarter ends. Put/call compares the value of puts and calls funds reported ($281K in puts, $885K in calls), leaving out market makers and bank trading desks. Not investment advice.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RNA is in one of them and how their past RNA trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered RNA in an article yet. Here's the latest on the wider market.